Automated Segmentation and Volumetry for Meningioma Using Deep Learning

Sponsor
Seoul National University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05093751
Collaborator
(none)
600
102.3

Study Details

Study Description

Brief Summary

U-Net-based architectures will be applied to 500 contrast-enhanced axial MR images of different patients from a single institution after manual segmentation of meningioma, of which 50 were used for testing. Tumor volumetry after autosegmentation by trained U-Net-based architecture is final goal.

Condition or Disease Intervention/Treatment Phase
  • Other: Observation

Detailed Description

U-Net-based architectures will be applied to 500 contrast-enhanced axial MR images of different patients from a single institution after manual segmentation of meningioma, of which 50 were used for testing. After preprocessing with Z-isotropification and intensity normalization of images, 3 U-Net-based networks (2D U-Net, Attention U-Net, 3D U-Net) and 3 nnU-Net-based networks (2D nnU-Net, Attention nnU-Net, 3D nnU-Net) will be trained with meningioma-segmented images. For applying to 3D networks, sagittal and coronal images will be reconstructed using axial images. After prediction, the cut-off of the probability function, which is a trade-off, will be obtained with the Gaussian Mixture Modeling algorithm using the probability density function. The voxels having a probability function higher than that will be finally predicted as meningioma. Tumor volume is calculated as the sum of the product of segmented area and thickness of axial images. For performance evaluation, dice similarity coefficient (DSC), precision, and recall will be evaluated compared with manually segmented voxels for validation datasets. The results of volumetry of each model will be compared with manual segmentation-based volume through Pearson's correlation analysis.

Study Design

Study Type:
Observational
Actual Enrollment :
600 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Automated Meningioma Segmentation and Volumetry Using a nnU-Net Based Architecture on Contrast-enhanced MRI
Actual Study Start Date :
Mar 23, 2013
Actual Primary Completion Date :
Sep 30, 2021
Actual Study Completion Date :
Sep 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Meningioma patients

Other: Observation
This study does not involve any intervention to subjects.

Outcome Measures

Primary Outcome Measures

  1. Accuracy compared with ground truth [10-01-2020 until 09-30-2021]

    As a primary endpoint, we will examine the ability of U-Net and nnU-Net to segment meningioma in brain MR compared with ground truth. Ground truth is defined as area on MR drawn by two neurosurgeons. Accuracy of autosegmentation of meningioma will be assessed in dice similarity coefficient, recall, and precision.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Radiologically diagnosed meningioma by MRI
Exclusion Criteria:
  • under 18 years old

  • Multiple meningiomas

  • Orbital meningioma

  • Any prior treatment for intracranial meningioma before registration

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Seoul National University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chul-Kee Park, Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT05093751
Other Study ID Numbers:
  • SNUH-MNG-AI001
First Posted:
Oct 26, 2021
Last Update Posted:
Oct 26, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Chul-Kee Park, Professor, Seoul National University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 26, 2021